Genetic engineers can design and assemble sophisticated gene circuits to program cells with new functions, but important ...

A team at Carnegie Mellon University is helping kids understand artificial intelligence with a soft, squishy, LED-lit neural ...

Dave Ball, who served as half of the English duo Soft Cell and perhaps best known for the 1981 hit “Tainted Love,” has died. He was 66. Marc Almond, Ball’s music partner and the other half of the ...

He was a producer and one half of the pioneering English synth-pop duo. By Aimee Ortiz Dave Ball, a producer and half of the English synth-pop duo Soft Cell, whose 1981 single “Tainted Love” became ...

Two siblings learned that a shopping trip for new phones was actually to buy the old fashion kind, a landline phone. Parker Schultz, 9, and his 10-year-old sister Paisley were really upset. Their ...

GameSpot may get a commission from retail offers. This month, Netflix debuted the new animated series, Splinter Cell: Deathwatch, which brings back Tom Clancy's Sam Fisher, the lead character of ...

Superintendents in four Connecticut districts that implemented cell phone bans over the past few years are seeing improvements in a number of areas. State Rep. Jennifer Leeper D-Fairfield, co-chair of ...

In 2006 immunologist and 2025 Nobel prize winner Shimon Sakaguchi co-wrote an article in Scientific American that now feels prophetic. In the story, entitled “Peacekeepers of the Immune System,” ...

Melanie Sepulveda, a Staten Island teacher, had her doubts about the new “bell-to-bell” cell phone ban in New York schools. In the past, she watched students drift through the hallways at I.S. 27 ...

Scientists identified two types of brain cells, neurons and microglia, that are altered in people with depression. Through genomic mapping of post-mortem brain tissue, they found major differences in ...

Oct 10 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab has decided to discontinue its cell therapy research and development efforts, a spokesperson for the Danish drugmaker told Reuters on Friday.

Novo Nordisk is ending all work in cell therapy, including a Type 1 diabetes program, amid CEO Maziar Mike Doustdar's reorganization. As part of the move, the company is laying off nearly all of the ...